You are here:

H-CCAT

Technology:

Implanted on:

H-CCAT: Development of new hybrid catalysts (based on carbon-hydrogen bonding) with high purity and activity for pharmaceutical applications limiting energy consumption and discharges.

The “H-CCAT” project for “Solid Catalysts for Activation of Aromatic C-H bonds” designs and formats hybrid catalysts based on carbon-hydrogen aromatic compounds. These catalysts have improved stability and better selectivity than the carbon-carbon catalysts currently used for these reactions. This work at the scale of nanoparticles aims to multiply the efficiency of the catalysts by ten. The catalysts are developed up to the demonstrator scale using effective one-step protocols, minimizing the use of solvents or the formation of waste. Axel’One operates synthesis tools and material formatting to allow the transition of the project to industrial scale. In particular, tests have been carried out on synthetic autoclave reactors. The flexible formatting processes preserve the porosity and activity of the catalysts. These new molecules will create very active pharmaceutical compounds that could be used in the treatment of diseases such as flu, cancer or AIDS.

FUNDING:

PARTNERS: 

KU Leuven
Axel’One
CNRS
Georg August Universitaet Goettingen
IKTS
Johnson Matthey
Janssen
ProfMOF
Sikémia
University of Perugia